BS Identity and Score for Krka

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Krka (krka.biz)

https://krka.biz 📍 Industry: Medical Devices, Pharma & Biotech
37 BS / 100

Krka is a high-substance corporate entity trapped in a low-substance marketing shell. While its headers are filled with generic wellness fluff, the site’s back-end—specifically its financial archives and news frequency—proves it is a legitimate industrial power. It is a rare case where the BS score is driven by technical omissions (schema) and cliché slogans rather than a lack of actual business substance.

Info Density Power-words vs. Substance ratio.
7
23% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
2
10% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint Detection of industry clichés/templates.
8
53% BS
Identity & Authority Expert verifiability & Schema depth.
10
67% BS

Immediately implement Organization and Person schema to bridge the technical authority gap and link to specific executive footprints. Replace the generic H2 ‘LIVING A HEALTHY LIFE’ with a substance-driven H1 that highlights the 70-year tenure and global generic market position. Add direct outbound links to peer-reviewed studies or clinical trial IDs under the ‘CLINICALLY PROVEN’ section to substantiate medical claims. Ensure all mentions of ‘renowned experts’ are accompanied by names and professional credentials to eliminate the expert-footprint gap.

Info Density Power-words vs. Substance ratio.
7 Impact Weight: 30 / 100
23% BS

The site exhibits high substance in its corporate and financial sections, citing specific figures like revenue of €565.8 million and an EBITDA margin of 31% for Q1 2026. However, fluff is concentrated in the marketing-heavy headings such as LIVING A HEALTHY LIFE and BECOME PART OF A DEDICATED TEAM. The body text for News is dense with specifics (2.4 tonnes of donations, 65 litres of blood), while product-related body text remains more generic, focusing on ‘high-quality’ without immediate technical specs. The specificity of the 70-year history and the detailed dividend proposals significantly offsets the power-word saturation in the hero sections.

AI treats every internal link as a semantic statement — not a navigation hint. Validate your entity level link signals and confirm whether your anchors reinforce meaning or generate noise.

Semantic Coherence Homepage promise vs. Sub-page reality.
2 Impact Weight: 20 / 100
10% BS

There is virtually zero semantic drift between the homepage signal and sub-page substance. The homepage claims Krka is a leading generic pharmaceutical company with 70 years of experience, and the Financial Reports sub-page provides empirical proof via an archive of annual reports stretching from 2002 to 2025. Employment pages maintain this identity by detailing specific areas of work for pharmacists and chemists, aligning the corporate promise with functional reality. The only minor drift is the clinical claims on the Health Matters page which are broader than the highly precise financial data found elsewhere.

Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.

Trust & Proof Verifiable evidence vs. Trust Theatre.
10 Impact Weight: 20 / 100
50% BS

The analysis detects Trust Theatre signals because the system identifies review counts (e.g., 10 on the homepage) without corresponding proof links (proof_links_count: 0). The claim CLINICALLY PROVEN is used as an H3 title, but the provided text lacks direct links to ClinicalTrials.gov identifiers or peer-reviewed citations in the immediate vicinity. While the site provides massive proof via its financial transparency, the consumer-facing trust signals (reviews) are technically unverified in this crawl.

The proof density is high but skewed toward corporate governance rather than clinical product data. The ratio of verifiable evidence (23+ years of annual reports, specific revenue/profit figures) to vague assertions is exceptional for the industry. While product-specific proof like ‘clinically proven’ lacks immediate external validation links in the crawl, the sheer volume of dated, specific financial documentation establishes a level of credibility that exceeds most generic pharmaceutical providers.

For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.

Commodity Fingerprint Detection of industry clichés/templates.
8 Impact Weight: 15 / 100
53% BS

The value proposition ‘Living a Healthy Life’ is a significant industry cliché that could be applied to any competitor in the pharma space. The site utilizes template-style fingerprints like ‘About us,’ ‘Sustainability,’ and ‘Contact us’ headings which are standard for large-cap corporate entities. Despite this, the fingerprint is saved from being entirely generic by the inclusion of the LJSE data source and the 70-year specific heritage claim. The positioning as a generic specialist is clear, though the marketing language used to describe it is boilerplate.

Identity & Authority Expert verifiability & Schema depth.
10 Impact Weight: 15 / 100
67% BS

A notable technical authority gap exists due to the total absence of JSON-LD schema (schema_json: null), which is unusual for a publicly traded entity claiming global leadership. While the site references ‘renowned experts’ on the Health Matters page, it fails to provide specific names, Person schema, or sameAs links to verify their digital footprint. The technical implementation, while functional, lacks the structured data signals that typically accompany high-authority medical or financial institutions in 2026.

There is a minor disconnect between the marketing tone of ‘courageous and visionary’ and the reality of being a generic manufacturer, which is inherently a follower-strategy model. However, the site’s financial performance claims are robustly supported by downloadable interim reports and preliminary results. Unlike fluff-heavy sites, Krka demonstrates its ‘stable dividend growth strategy’ with 13.6% average increases, providing the exact proof that its marketing slogans lack.

Medical Devices, Pharma & Biotech BS: Krka (krka.biz)

BS: 37/ 100

The site perfectly aligns with the Pharmaceutical and Biotech category, emphasizing its role as a generic drug manufacturer. The content supports this through detailed financial reporting, regulatory news, and product category listings for prescription and animal health.

Before embeddings, before entities, before retrieval — the crawler must reach the text. Open the Crawlability & Indexation Guide to learn how access failures erase meaning long before interpretation begins.

“The score of 37 reflects a company with immense substance that under-utilizes technical trust signals. The primary drivers of the score are the lack of structured data (Identity & Authority) and the use of 'Trust Theatre' review flags without verified external proof links. The remarkably low Semantic Coherence score (representing high consistency) prevents the BS score from reaching the moderate range.”

To understand and learn thinking like AI, visit our educational environment (Krka example) that uses the same data this audit was generated from, and try it yourself.
Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY